Uses
Triple therapy for insulin resistance in Type 2 Diabetes Mellitus
Antidiabetic & Neuropathy
GLIMMED P
Product Composition
Glimepiride 2mg + Metformin 500mg ER + Pioglitazone 15 mg Tab
Product Uses
Triple therapy for insulin resistance in Type 2 Diabetes Mellitus
Maximum Retail PriceRecommended Consumer Price
₹ 12010*10
Product Overview
GLIMMED P combines Glimepiride, Metformin, and Pioglitazone to provide triple-action glycemic control for insulin-resistant type-2 diabetic patients.
| Composition | Glimepiride 2mg + Metformin 500mg ER + Pioglitazone 15 mg Tab |
|---|---|
| Strength | 2mg + 500mg + 15mg |
| Pack Size | 10*10 |
| Maximum Retail Price (MRP) | ₹ 120 per strip/box |
| Therapeutic Category | Antidiabetic & Neuropathy |
Key Efficacy & Benefits
Increases insulin release from the pancreas, increases peripheral glucose uptake, and reduces central obesity and VLDL.
Dosage & Administration
Take once daily with breakfast or as directed by the physician.
Specifications
GLIMMED P
Category:Tablets
Form:10*10
Status:Available
Product Order Form
Direct Commercial Order RequestSubmit your commercial order request for GLIMMED P. Your order details will be routed directly to info@medgraaft.in.